Names and pronunciation
(eye′va-kaf′tor) Kalydeco
PDF page 733
Drug reference
(eye′va-kaf′tor) Kalydeco
PDF page 733
Func. class.: Respiratory agent
PDF page 733
USES: Cystic fibrosis in those with G551D, G1244E, G1349D, G178R, G5515S, S1255P, S549N, S549R mutation in the CFTR gene
PDF page 733
DOSAGE AND ROUTES • Adult/adolescent/child ≥6 yr: PO 150 mg q12hr with fat-containing food Child 4-6 mon, ≥5 kg: PO One 25-mg packet of granules q12 hr with fat- containing food; 6 mo-<6 yr, 5-<7 kg: One 25-mg packet of granules q12 hr; mix with fat containing food; 6-<6 yr, 7- <14 kg: One 50-mg packet of granules q12hr; mix with fat containing food; 6 mo-<6 yr, ≥14 kg: One 75-mg packet of granules q12hr with fat containing food
PDF page 733
• Adult/adolescent/child ≥6 yr: PO 150 mg q12hr with fat-containing food Child 4-6 mon, ≥5 kg: PO One 25-mg packet of granules q12 hr with fat- containing food; 6 mo-<6 yr, 5-<7 kg: One 25-mg packet of granules q12 hr; mix with fat containing food; 6-<6 yr, 7- <14 kg: One 50-mg packet of granules q12hr; mix with fat containing food; 6 mo-<6 yr, ≥14 kg: One 75-mg packet of granules q12hr with fat containing food
PDF page 733